Angina pectoris is a symptom complex that arises when the myocardial oxygen demand exceeds supply, typically due to partial obstruction of the coronary arteries. The term “angina” is often associated with transient episodes of chest discomfort, pressure, or tightness that may radiate to the shoulders, arms, neck, jaw, or back. The primary objective of this article is to provide an accurate and neutral overview of angina pectoris, explaining its physiological basis, clinical manifestations, and the general principles underlying its assessment and care.
Key questions addressed include:
Angina pectoris is defined as chest discomfort or pain resulting from myocardial ischemia, a state in which the heart muscle receives insufficient oxygen-rich blood to meet its metabolic demands. Episodes are usually transient, lasting from a few minutes to around 15 minutes, and are often triggered by physical exertion, emotional stress, or other factors that increase myocardial oxygen demand.
Angina is commonly categorized into the following types:
Stable angina
Unstable angina
Variant (Prinzmetal) angina
Microvascular angina
Angina is a common manifestation of ischemic heart disease and is prevalent among adults with cardiovascular risk factors such as hypertension, diabetes, hyperlipidemia, and smoke history. It may also appear in individuals with non-obstructive coronary disease.
The heart relies on a balance between oxygen supply and demand. Oxygen is delivered through the coronary arteries and consumed by cardiac myocytes to generate energy via aerobic metabolism. Factors affecting this balance include:
A major cause of angina is atherosclerosis, the buildup of plaque within the coronary arteries. Plaque narrows the vessel lumen, limiting blood flow, particularly during periods of increased myocardial demand.
In variant angina, transient spasm of a coronary artery reduces oxygen delivery despite the absence of significant plaque. The exact mechanisms involve endothelial dysfunction, smooth muscle hyperreactivity, and autonomic nervous system influences.
Microvascular angina involves abnormal function of the smaller coronary vessels, which may impair perfusion even when larger arteries appear unobstructed. Contributing factors include endothelial dysfunction, inflammation, and altered vasodilatory responses.
Reduced oxygen availability leads to accumulation of metabolic byproducts such as lactate and adenosine. These compounds stimulate cardiac nerve endings, producing the characteristic sensation of chest discomfort or pressure.
Angina is typically described as:
The duration is usually brief, with relief occurring after rest or removal of the triggering factor.
Assessment generally involves:
Additional laboratory evaluation may include biomarkers of myocardial injury, lipid profile, and other cardiovascular risk assessments.
Management of angina involves general strategies to reduce ischemia and monitor symptoms:
The choice of approach depends on individual patient characteristics, risk stratification, and underlying pathophysiology.
Regular follow-up is often recommended for individuals with recurrent angina. Monitoring includes assessment of symptom frequency, triggers, exercise tolerance, and response to therapy. Prompt evaluation is advised if there is an increase in severity or frequency of symptoms.
Angina pectoris represents a clinical manifestation of myocardial ischemia and can result from multiple mechanisms, including coronary artery disease, vasospasm, and microvascular dysfunction. Understanding the condition requires recognition of its pathophysiology, symptom patterns, and clinical evaluation methods.
Ongoing research explores advances in non-invasive imaging, biomarkers, and novel therapeutic approaches aimed at improving patient outcomes and quality of life. Emerging technologies also aim to better characterize microvascular dysfunction and personalize management strategies.
Q1: What is the primary cause of angina pectoris?
Reduced blood flow to the heart muscle, often due to atherosclerotic narrowing of the coronary arteries, is the most common cause.
Q2: How does stable angina differ from unstable angina?
Stable angina occurs predictably with exertion and is relieved by rest, while unstable angina may occur at rest or with minimal activity and often indicates higher cardiovascular risk.
Q3: What role do microvessels play in angina?
Microvascular angina involves dysfunction in small coronary vessels that can impair oxygen delivery even when large arteries are unobstructed.
Q4: How is angina evaluated in a clinical setting?
Evaluation includes history taking, physical examination, ECG, stress testing, and sometimes imaging of the coronary arteries.
Q5: Why is monitoring of angina important?
Changes in frequency, severity, or triggers may indicate progression of underlying heart disease and require timely assessment.
Q6: Can angina occur without significant artery blockage?
Yes, variant angina and microvascular angina can occur even without major obstructive lesions in the coronary arteries.
https://www.heart.org/en/health-topics/angina
https://www.ncbi.nlm.nih.gov/books/NBK459455/
https://www.ahajournals.org/doi/10.1161/CIR.0000000000000877
https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
https://www.ncbi.nlm.nih.gov/books/NBK500027/
https://www.uptodate.com/contents/overview-of-angina-pectoris
https://www.mayoclinic.org/diseases-conditions/angina/symptoms-causes/syc-20369373
https://www.cdc.gov/heartdisease/angina.htm